Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon

Journal of Medical Virology

Volumn 52, Issue 1, 1997, Pages 105-112

  Trabaud, M A ^a   Bailly, F ^b   Si Ahmed, S N ^b   Chevallier, P ^c   Sepetjan, M ^c   Colucci, G ^d   Trepo C ^a,b,e  

^a U de Rech sur les Hepatites   (France)

^b HÔTEL DIEU   (France)

^c UNIVERSITÉ LYON 1   (France)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e INSERM   (France)

Author keywords

HCV RNA assays; monitoring therapy; sensitivity

Indexed keywords

INTERFERON; RIBAVIRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; HEPATITIS C; HUMAN; MALE; PATIENT MONITORING; QUANTITATIVE ASSAY; RNA ANALYSIS;

ADULT; AGED; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERONS; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VIRAL LOAD;

CHIRON; HEPATITIS C VIRUS;

EID: 0030957235     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199705)52:1<105::AID-JMV17>3.0.CO;2-L     Document Type: Article

References (20)

1. Bizollon T, Palazzo U, Sciarrino E, Ducerf C, Trepo C (1996): Control of HCV recurrence after OLT by prolonged ribavirin therapy following initial combination with interferon. Journal of Hepatology 25 (suppl 1):62.
2. Bresters D, Cuypers HTM, Reesink HW, Mauser-Bunschoten EP, Van Den Berg HM, Schaasberg WP, Wilber JC, Urdea MS, Neuwald P, Lelie PN (1994): Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial. Journal of Medical Virology 43:262-268.
3. Clossais Besnard N, Andre PM (1994): Automated quantitative determination of hepatitis C virus viremia by reverse transcription-PCR. Journal of Clinical Microbiology 32:1887-1893.
4. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Deinstag JL, Vanthiel DH, Tamburro G., Lefkowitch J, Albrecht J, Meschievitz C, Ortego T, Gibas A, and the Hepatitis International Therapy Group (1989): Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized controlled trial. New England Journal of Medicine 321:1501-1506.
5. Di Bisceglie A, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH (1989): Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. New England Journal of Medicine 321:1506-1510.
6. Gretch D, Corey L, Wilson J., Dela Rosa C, Willson R, Carithers Jr R, Busch M, Hart J, Sayers M, Han J (1994): Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: High titer viremia correlates with advanced stage of disease. Journal of Infectious Disease's 169:1219-1225.
7. Hino K, Sainokami S, Shimoda K, Iino S, Okamoto H, Miyakawa Y, Mayumi M (1994): Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. Journal of Medical Virology 42:299-305.
8. Kumar U, Thomas HC, Monjardino J (1994): Serum HCV RNA levels in chronic HCV hepatitis measured by quantitative PCR assay; correlation with serum AST. Journal of Virological Methods 47: 95-102.
9. Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC (1993a): Significance of serum hepatitis C RNA levels in chronic hepatitis C. The Lancet 341:1501-1504.
10. Lau JYN, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL (1993b): Discrepancy between biochemical and virological responses to interferon-α in chronic hepatitis C. The Lancet 342: 1208-1209.
11. Li J-S, Tong S-P, Vitvitski L, Trepo C (1995): Single-step nested polymerase chain reaction for detection of different genotypes of hepatitis C virus. Journal of Medical Virology 45:151-155.
12. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger S (1995): Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus factors of sustained response to interferon alpha therapy in chronic hepatitis C. Hepatology 22: 1050-1056.
13. Orito E, Mizokami M, Nakano T, Terashima H, Nojiri O, Sakakibara K, Mizuno M, Ogino M, Nakamura M, Matsumoto Y, Miyata K-I, Lau JYN (1994): Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C. Journal of Medical Virology 44: 410-414.
14. Ravaggi A, Zonaro A, Mazza C, Albertini A, Cariani E (1995): Quantification of hepatitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microtiter plates. Journal of Clinical Microbiology 33:265-269.
15. Roth WK, Lee J-H, Rüster B, Zeuzem S (1996): Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. Journal of Clinical Microbiology 34:261-264.
16. Shindo M, Di Bisceglie AM, Silver J, Limjoco T, Hoofnagle JH, Feinstone SM (1994): Detection and quantification of hepatitis C virus RNA in serum using the polymerase chain reaction and a colorimetric enzymatic detection system. Journal of Virological Methods 48:65-72.
17. Shindo M, Arai K, Sokawa Y, Okuno T (1995): Hepatitis C virus RNA as a predictor of a long-term response to interferon-α therapy. Annals of Internal Medicine 122:586-591.
18. Trepo C, Habersetzer F, Bailly F, Berby F, Pichoud C, Berthillon P, Vitvitski L (1994): Interferon therapy for hepatitis C. Antiviral Research 24:155-163.
19. Whitby K, Garson JA (1995): Optimisation and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C RNA. Journal of Virological Methods 51:75-88.
20. Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Tsuji T, Shin S, Tanno M, Urdea MS, Kolberg JA (1995): Efficacy of interferon alpha therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 22:1351-1354.